These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 1566458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pretransplant donor antigen and cyclophosphamide in the evaluation of the clonal deletion theory in the hamster to Lewis rat cardiac xenograft model.
    Boyle EM, Fischel RJ, Johnson EM, Leventhal J, Matas AJ, Bolman RM.
    Transplant Proc; 1992 Apr; 24(2):698. PubMed ID: 1566486
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
    Blakely ML, Van der Werf WJ, Dalmasso AP, Bach FH.
    Transplant Proc; 1994 Jun; 26(3):1374-5. PubMed ID: 8029946
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of splenectomy as adjunctive therapy in suppressing cardiac xenograft humoral immunity.
    Carobbi A, Araneda D, Marchman W, Patselas T, Thomas F, Thomas J.
    Transplant Proc; 1992 Apr; 24(2):521-2. PubMed ID: 1566414
    [No Abstract] [Full Text] [Related]

  • 10. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats.
    Lin Y, Vandeputte M, Waer M.
    Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prolongation of cardiac xenograft survival by pre- and posttransplant splenectomy is associated with a decrease in anti-donor antibody titers.
    Quarantillo P, Araneda D, Thomas F, Thomas J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):387-8. PubMed ID: 8438347
    [No Abstract] [Full Text] [Related]

  • 13. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012
    [No Abstract] [Full Text] [Related]

  • 14. Recipient pretreatment permits long-term xenograft survival on a relatively low dose cyclosporine maintenance therapy.
    Bouwman E, de Bruin RW, Jeekel J, Marquet RL.
    Transplant Proc; 1992 Apr; 24(2):519-20. PubMed ID: 1566413
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs.
    Braidley PC, Dunning JJ, Wallwork J, White DJ.
    Transplant Proc; 1994 Jun; 26(3):1259-60. PubMed ID: 8029901
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effect of splenectomy on cardiac and liver xenografts in the nude rat.
    Tsugita M, Valdivia LA, Woo J, Demetris AJ, Celli S, Pan F, Frye C, Fung JJ.
    Transplant Proc; 1994 Jun; 26(3):1210. PubMed ID: 8029890
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.